Burkart F
Schweiz Med Wochenschr. 1983 Dec 17;113(50):1898-903.
In patients without heart failure and with exercise-induced angina pectoris, betablockers are still the treatment of choice. The pharmacological differences within the betablockers are of minor importance clinically. Patients with angina at rest, or with a considerably changing effort threshold, are suspect for additional coronary spasms. Here calcium antagonists, and possibly nitrates, should be given first. A combination of these three treatments often proves beneficial. Amiodarone, which in the beginning was only rarely used because of its complex pharmacokinetics, is now generally accepted as an effective and well-tolerated drug for angina. In unstable angina, medical treatment varies according to the differing clinical symptoms. In addition to immobilization and anticoagulation, prolonged pain attacks are treated with intravenous nitrates. If the symptoms persist, combination of antianginal drugs as described above, sometimes in high doses, is necessary in order to postpone selective coronary angiography and bypass operation by one to two weeks. Otherwise these procedures must be performed after intraaortic balloon pumping has been instituted.
对于没有心力衰竭且患有运动诱发性心绞痛的患者,β受体阻滞剂仍然是首选治疗药物。β受体阻滞剂之间的药理学差异在临床上不太重要。静息性心绞痛患者或运动耐力阈值变化较大的患者,可能存在额外的冠状动脉痉挛。在此情况下,应首先给予钙拮抗剂,可能还需给予硝酸盐类药物。这三种治疗方法联合使用往往证明是有益的。胺碘酮最初因其复杂的药代动力学而很少使用,现在已被普遍认为是一种治疗心绞痛有效且耐受性良好的药物。在不稳定型心绞痛中,药物治疗根据不同的临床症状而有所不同。除了制动和抗凝外,持续性疼痛发作采用静脉注射硝酸盐类药物治疗。如果症状持续,为了将选择性冠状动脉造影和搭桥手术推迟一到两周,有时需要大剂量使用上述抗心绞痛药物联合治疗。否则,这些手术必须在主动脉内球囊反搏建立后进行。